Huiwen Miao - Publications

Multi-omics analysis reveals insights into the differentiation between radiological subtypes of early lung adenocarcinoma.

Journal: Clinical and translational medicine

Published: April 25, 2026

Systematic evaluation of blood contamination in nanoparticle-based plasma proteomics.

Journal: EMBO molecular medicine

Published: November 10, 2025

15-Deoxy-Δ-12,14-Prostaglandin J2 Represses Immune Escape of Lung Adenocarcinoma by Polarizing Macrophages Through Epidermal Growth Factor Receptor/Ras/Raf Pathway.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: September 11, 2024

Disease burden and related risk factors of esophageal cancer in China and globally from 1990 to 2021, with forecast to 2035: An analysis and comparison.

Journal: Tobacco induced diseases

Published: May 16, 2024

Efficacy of digital therapeutics for perioperative management in patients with lung cancer: a randomized controlled trial.

Journal: BMC medicine

Published: March 03, 2024

Benefits and Relevant Risk Factor Assessment of Neoadjuvant Chemotherapy in Combination with Surgery in Limited-Stage Small-Cell Lung Cancer.

Journal: Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer

Published: April 05, 2023

miR-1-3p/CELSR3 Participates in Regulating Malignant Phenotypes of Lung Adenocarcinoma Cells.

Journal: Current gene therapy

Published: November 03, 2020

Circulating cell-free DNA as a diagnostic and prognostic biomarker for non-small-cell lung cancer: a systematic review and meta-analysis.

Journal: Biomarkers in medicine

Published: December 18, 2019